BioPharma.
company in Jílové u Prahy, Czech Republic
- Reports this week
- 1
- Active events
- 2
- Connections
- 63
What's happening
Active this week
One to three months ago
-
The finance sector is encountering unique challenges related to biopharma, driven by the accelerating adoption of advanced technologies.Some support2 reports1 development inside
-
Definitive Healthcare launched its Turbo AI platform and noted improving activity within the biopharma sector.Some support1 report
-
BioPharma appoints a new US head and secures US plasma supply, while Grifols reorganizes its operating model.Some support1 report
-
BioPharma organizations are targeted by the agreement in Santa Clara.Some support1 report1 development inside
-
A director of BioPharma purchased company shares on June 30, 2026.Some support1 report
Gone quiet
No new reports in 90+ days-
BioPharma was listed on the electronic stock exchange on June 17, 2026.Some support1 report
-
Cantor Fitzgerald reiterated an overweight rating on BioPharma shares, reducing the target price and setting a buy rating.Some support4 reports
-
BioPharma announced results from San Francisco on August 15, 2025, with Michael Breen as Executive Chairman and CEO.Some support1 report
-
BioPharma, led by Michael Breen, held meetings at a conference in New York City in September 2025.Some support1 report1 development inside
-
Tariffs and uncertainty, coupled with slow stimulus activity in China, are delaying biopharma investments.Some support2 reports6 developments inside
-
Company announced trial initiation from San Francisco on August 11, 2025.Some support2 reports
-
CORT submitted an FDA application for relacorilant, while AI stocks continue to benefit from Trump-era tariffs.Some support2 reports
-
Ecolab's acquisition of Purolite is aimed at addressing the growing demand within the biopharma sector.Speculative1 report
-
Virtusa provides digital services to help biopharma clients digitize their value chain.Some support1 report
-
RAC provides modular hardware and Catalyst scheduling software to clients in the biopharma sector, including Ginkgo Bioworks.Some support1 report1 development inside
-
FDA decisions are noted to be driving momentum within the biopharma industry.Some support1 report
-
BioPharma and OncoX BioPharma signed a strategic licensing agreement for oncology development.Some support1 report
-
Richard Tobin cited positive margin mix from growth platforms for BioPharma.Some support1 report
-
ABVC licensed four IND-stage drug assets to OncoX BioPharma on August 1, 2025.Some support1 report
-
ClearPoint Neuro appointed Joe Burnett as President and CEO and formed new partnerships with BioPharma on August 13, 2025.Some support1 report
-
Companies FSS, Avantor, BioPharma, and Enova detailed their diverse business profiles, including financial services and mission-critical products.Some support2 reports3 developments inside
-
An AI assistant is being used to aid regulatory professionals within the biopharma industry.Some support2 reports
-
BioPharma commercialized its therapeutics in the United States on August 17, 2025.Some support1 report
-
BioPharma received a milestone payment for the Vitargus(R) licensing deal from ForSeeCon Eye Corporation.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around BioPharma this week
News at the entities that move BioPharma most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves BioPharma
-
Christina Kay StructuralIntegrated BioPharma announced financial results from Hillside, NJ, on September 25, 2026. The company is co-led by Christina Kay.Moves BioPharma
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves BioPharma
-
Ecolab StructuralEcolab provides advanced products for semiconductor manufacturing, involving both Ecolab and GlobalFoundries.Moves BioPharma
-
MarketBeat Mentioned togetherMarketBeat aggregates data on IDT Corporation stock performance.Moves BioPharma
-
Veeva Systems OperationalVeea Inc. is listed on the Nasdaq stock exchange, and Geode Capital Management LLC raised its stake in the company, filing with the SEC.Moves BioPharma
Connections
The 19 strongest of 63, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Christina Kay Structural
Christina Kay serves as Co-CEO of BioPharma.
-
FDA Structural
The FDA functions as the formal regulatory body responsible for reviewing, approving, and setting the market path for BioPharma products and applications.
-
Nasdaq Structural
BioPharma is a publicly traded company listed and traded on the Nasdaq stock exchange.
-
Felipe Palacios Structural
Felipe Palacios holds a leadership position at BioPharma US.
-
Fresenius Kabi Structural
Fresenius Kabi employs the President of BioPharma, indicating a formal organizational link.
-
Ecolab Structural
Ecolab provides process development and specialized solutions to support BioPharma's operational needs.
-
Veeva Systems Operational
Veeva Systems actively secures contracts and achieves adoption within the BioPharma industry.
-
Sungkyunkwan University Operational
BioPharma and Sungkyunkwan University have formed a partnership for focused ultrasound market entry.
Show all 19 connections
-
Bruker Operational
BioPharma market demand and conditions directly influence the performance of Bruker's BioSpin segment.
-
MarketBeat Mentioned together
MarketBeat tracks and reports financial metrics, including average ratings and consensus targets, for BioPharma.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald provided an overweight rating on shares within the BioPharma sector.
-
GLP Operational
BioPharma and GLP have initiated a current statement of work for preclinical services.
-
Truist Financial Mentioned together
Truist Financial provided positive financial coverage, including raising price targets and issuing a buy rating, for BioPharma.
-
Citigroup Mentioned together
Citigroup provides investment ratings and target price adjustments for BioPharma.
-
Grifols Shared context
Both companies operate within the same highly regulated US life sciences market, specifically regarding plasma supply and operational models.
-
IQVIA Mentioned together
The relationship is based on a single snapshot labeling the companies as competitors in a specific geographic and industry context.
-
Santa Clara Shared context
BioPharma organizations are situated and targeted by agreements within the Santa Clara area.
-
James Huang Structural
James Huang holds a formal role as a director and shareholder in BioPharma.
-
Repligen Mentioned together
Both entities are mentioned in the context of general market trends and funding within the biopharma sector.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
1 eventJuly 2026
3 events- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
- The finance sector is encountering unique challenges related to biopharma, driven by the accelerating adoption of advanced technologies.
- BioPharma appoints a new US head and secures US plasma supply, while Grifols reorganizes its operating model.
Show 1 earlier month
June 2026
21 events- BioPharma organizations are targeted by the agreement in Santa Clara.
- A director of BioPharma purchased company shares on June 30, 2026.
- BioPharma was listed on the electronic stock exchange on June 17, 2026.
- Cantor Fitzgerald reiterated an overweight rating on BioPharma shares, reducing the target price and setting a buy rating.
- BioPharma announced results from San Francisco on August 15, 2025, with Michael Breen as Executive Chairman and CEO.
- BioPharma, led by Michael Breen, held meetings at a conference in New York City in September 2025.
- Tariffs and uncertainty, coupled with slow stimulus activity in China, are delaying biopharma investments.
- Company announced trial initiation from San Francisco on August 11, 2025.
- CORT submitted an FDA application for relacorilant, while AI stocks continue to benefit from Trump-era tariffs.
- Ecolab's acquisition of Purolite is aimed at addressing the growing demand within the biopharma sector.
- Virtusa provides digital services to help biopharma clients digitize their value chain.
- RAC provides modular hardware and Catalyst scheduling software to clients in the biopharma sector, including Ginkgo Bioworks.
- FDA decisions are noted to be driving momentum within the biopharma industry.
- BioPharma and OncoX BioPharma signed a strategic licensing agreement for oncology development.
- Richard Tobin cited positive margin mix from growth platforms for BioPharma.
- ABVC licensed four IND-stage drug assets to OncoX BioPharma on August 1, 2025.
- ClearPoint Neuro appointed Joe Burnett as President and CEO and formed new partnerships with BioPharma on August 13, 2025.
- Companies FSS, Avantor, BioPharma, and Enova detailed their diverse business profiles, including financial services and mission-critical products.
- An AI assistant is being used to aid regulatory professionals within the biopharma industry.
- BioPharma commercialized its therapeutics in the United States on August 17, 2025.
- BioPharma received a milestone payment for the Vitargus(R) licensing deal from ForSeeCon Eye Corporation.